Short-Acting Testosterone Replacement Therapy Better for Spermatogenesis
Study authors hypothesized that longer-acting testosterone replacement therapy will have significant impact on suppressing HPG axis compared with short-acting TRT preparations.
Testosterone Deficiency
Treatment With Testosterone Significantly Reduces T2D Risk
Overweight or obese men frequently have low serum testosterone concentrations, which is associated with increased risk of type 2 diabetes.
Testosterone Levels Increased in Third Trimester Pregnancy in PCOS
Investigators examine total testosterone, free testosterone, and sex hormone binding globulin levels in pregnant women in the third trimester with PCOS.
Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome
This finding suggests that clinicians should monitor anxiety among individuals with testosterone deficiency and XXY.
Testosterone Prescribing Trends in the United States Between 2002 and 2016
In 2014, the US Food and Drug Administration issued a safety bulletin for the use of testosterone.
Effect of Testosterone Replacement on Glycemic Control in Obese Men With Hypogonadism, T2D
Investigators examined the effect of testosterone replacement therapy on metabolic syndrome and vascular function in obese males with hypogonadism.
AUA: New Guidelines for Diagnosis, Management of Testosterone Deficiency
Clinicians should use a total testosterone level below 300ng/dL as a reasonable cut-off in support of the diagnosis of low testosterone.
Updated Clinical Practice Guidelines on Testosterone Therapy in Men With Hypogonadism
Testosterone therapy is recommended in men with hypogonadism to correct symptoms of testosterone deficiency. Men who are otherwise healthy do not need to be screened for hypogonadism.
Testosterone Therapy Prescribing Practices in VA Setting
Patients attending VA clinics may experience variability in testosterone prescribing practices for hypogonadism.
Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes
At 12 years of testosterone treatment, HbA1c decreased to 5.5±0.3%.
-
Loading...
-
Loading...
Next post in ADA 77th Scientific Sessions 2017
